Insider Trading Alert - BSFT, AMBA, GOOG, ADT And NVAX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 4, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $408.12 to $109,651,973.50.

Highlighted Stocks Traded by Insiders:

BroadSoft (BSFT) - FREE Research Report

ILL Charles L who is Director at BroadSoft bought 500 shares at $30.61 on Feb. 4, 2014. Following this transaction, the Director owned 14,782 shares meaning that the stake was reduced by 3.5% with the 500-share transaction.

The shares most recently traded at $29.86, down $0.75, or 2.51% since the insider transaction. Historical insider transactions for BroadSoft go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,832
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 10,832
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 81,554

The average volume for BroadSoft has been 386,500 shares per day over the past 30 days. BroadSoft has a market cap of $854.8 million and is part of the technology sector and computer software & services industry. Shares are up 10.8% year-to-date as of the close of trading on Tuesday.

BroadSoft, Inc. provides software and services that enable mobile, fixed-line, and cable service providers to deliver hosted or cloud-based unified communications and other voice and multimedia services over Internet protocol (IP) based networks. Currently there are 4 analysts that rate BroadSoft a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSFT - FREE

TheStreet Quant Ratings rates BroadSoft as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full BroadSoft Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ambarella (AMBA) - FREE Research Report

Kohn Leslie who is Cto at Ambarella sold 42,000 shares at $30.64 on Feb. 4, 2014. Following this transaction, the Cto owned 1.0 million shares meaning that the stake was reduced by 3.96% with the 42,000-share transaction.

Wang Feng-Ming who is Ceo at Ambarella sold 73,500 shares at $30.79 on Feb. 4, 2014. Following this transaction, the Ceo owned 442,470 shares meaning that the stake was reduced by 14.25% with the 73,500-share transaction.

The shares most recently traded at $25.44, down $5.35, or 21.02% since the insider transaction. Historical insider transactions for Ambarella go as follows:

  • 4-Week # shares sold: 21,083
  • 12-Week # shares sold: 385,129
  • 24-Week # shares sold: 758,378

The average volume for Ambarella has been 1.4 million shares per day over the past 30 days. Ambarella has a market cap of $857.1 million and is part of the technology sector and electronics industry. Shares are down 10.36% year-to-date as of the close of trading on Tuesday.

Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display. The company has a P/E ratio of 39.5. Currently there is 1 analyst that rates Ambarella a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMBA - FREE

TheStreet Quant Ratings rates Ambarella as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the stock itself is trading at a premium valuation. Get the full Ambarella Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Google (GOOG) - FREE Research Report

Drummond David C who is SVP, Corporate Development at Google sold 6,014 shares at $1,158.36 on Feb. 4, 2014. Following this transaction, the SVP, Corporate Development owned 0 shares meaning that the stake was reduced by 100% with the 6,014-share transaction.

The shares most recently traded at $1,135.00, down $23.36, or 2.06% since the insider transaction. Historical insider transactions for Google go as follows:

  • 4-Week # shares sold: 985
  • 12-Week # shares sold: 2,317
  • 24-Week # shares sold: 12,064

The average volume for Google has been 2.0 million shares per day over the past 30 days. Google has a market cap of $313.6 billion and is part of the technology sector and internet industry. Shares are up 1.56% year-to-date as of the close of trading on Tuesday.

Google Inc., a technology company, builds products and provides services to organize the information and make it universally accessible and useful. The company has a P/E ratio of 32.6. Currently there are 26 analysts that rate Google a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GOOG - FREE

TheStreet Quant Ratings rates Google as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Google Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ADT Corporation (ADT) - FREE Research Report

Geltzeiler Michael S who is Chief Financial Officer at ADT Corporation bought 10,000 shares at $29.59 on Feb. 4, 2014. Following this transaction, the Chief Financial Officer owned 31,900 shares meaning that the stake was reduced by 45.66% with the 10,000-share transaction.

Daly Richard J who is Director at ADT Corporation bought 3,000 shares at $30.21 on Feb. 4, 2014. Following this transaction, the Director owned 3,510 shares meaning that the stake was reduced by 588.24% with the 3,000-share transaction.

Colligan Thomas J who is Director at ADT Corporation bought 3,000 shares at $30.25 on Feb. 4, 2014. Following this transaction, the Director owned 12,285 shares meaning that the stake was reduced by 32.31% with the 3,000-share transaction.

Boerema Donald A. who is Chief Corp. Dev. Officer at ADT Corporation bought 500 shares at $29.47 on Feb. 4, 2014. Following this transaction, the Chief Corp. Dev. Officer owned 33,865 shares meaning that the stake was reduced by 1.5% with the 500-share transaction.

The shares most recently traded at $30.03, up $0.56, or 1.87% since the insider transaction. Historical insider transactions for ADT Corporation go as follows:

  • 24-Week # shares bought: 1,500

The average volume for ADT Corporation has been 4.2 million shares per day over the past 30 days. ADT Corporation has a market cap of $5.3 billion and is part of the services sector and diversified services industry. Shares are down 25.38% year-to-date as of the close of trading on Tuesday.

The ADT Corporation provides electronic security, interactive home and business automation, and related monitoring services under the ADT, ADT Pulse, and Companion Service brands to residential and small business customers in the United States and Canada. The stock currently has a dividend yield of 2.77%. The company has a P/E ratio of 15.7. Currently there is 1 analyst that rates ADT Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ADT - FREE

TheStreet Quant Ratings rates ADT Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and weak operating cash flow. Get the full ADT Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Novavax (NVAX) - FREE Research Report

Phillips Barclay A who is SVP, Chief Financial Officer at Novavax bought 9,868 shares at $2.29 on Feb. 4, 2014. Following this transaction, the SVP, Chief Financial Officer owned 9,868 shares meaning that the stake was reduced by 100% with the 9,868-share transaction.

Glenn Gregory M who is SVP, Research and Development at Novavax bought 4,102 shares at $2.29 on Feb. 4, 2014. Following this transaction, the SVP, Research and Development owned 31,000 shares meaning that the stake was reduced by 15.25% with the 4,102-share transaction.

Wilson Russell P who is SVP, Business Development at Novavax bought 4,900 shares at $2.29 on Feb. 4, 2014. Following this transaction, the SVP, Business Development owned 54,900 shares meaning that the stake was reduced by 9.8% with the 4,900-share transaction.

Erck Stanley C who is President and CEO at Novavax bought 11,868 shares at $2.29 on Feb. 4, 2014. Following this transaction, the President and CEO owned 74,868 shares meaning that the stake was reduced by 18.84% with the 11,868-share transaction.

Hahn Timothy Jon who is SVP, Manufacturing & PD at Novavax bought 9,416 shares at $2.29 on Feb. 4, 2014. Following this transaction, the SVP, Manufacturing & PD owned 80,416 shares meaning that the stake was reduced by 13.26% with the 9,416-share transaction.

The shares most recently traded at $5.21, up $2.92, or 56.05% since the insider transaction. Historical insider transactions for Novavax go as follows:

  • 24-Week # shares bought: 100,000

The average volume for Novavax has been 5.4 million shares per day over the past 30 days. Novavax has a market cap of $1.1 billion and is part of the health care sector and drugs industry. Shares are up 3.52% year-to-date as of the close of trading on Tuesday.

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. Currently there are 4 analysts that rate Novavax a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NVAX - FREE

TheStreet Quant Ratings rates Novavax as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and weak operating cash flow. Get the full Novavax Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists